Your browser doesn't support javascript.
loading
Molecular Properties of Human Guanylate Cyclase-Activating Protein 3 (GCAP3) and Its Possible Association with Retinitis Pigmentosa.
Avesani, Anna; Bielefeld, Laura; Weisschuh, Nicole; Marino, Valerio; Mazzola, Pascale; Stingl, Katarina; Haack, Tobias B; Koch, Karl-Wilhelm; Dell'Orco, Daniele.
Afiliação
  • Avesani A; Section of Biological Chemistry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
  • Bielefeld L; Division of Biochemistry, Department of Neuroscience, University of Oldenburg, 26111 Oldenburg, Germany.
  • Weisschuh N; Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
  • Marino V; Section of Biological Chemistry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
  • Mazzola P; Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
  • Stingl K; University Eye Hospital, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
  • Haack TB; Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
  • Koch KW; Centre for Rare Diseases, University of Tübingen, 72076 Tübingen, Germany.
  • Dell'Orco D; Division of Biochemistry, Department of Neuroscience, University of Oldenburg, 26111 Oldenburg, Germany.
Int J Mol Sci ; 23(6)2022 Mar 17.
Article em En | MEDLINE | ID: mdl-35328663
ABSTRACT
The cone-specific guanylate cyclase-activating protein 3 (GCAP3), encoded by the GUCA1C gene, has been shown to regulate the enzymatic activity of membrane-bound guanylate cyclases (GCs) in bovine and teleost fish photoreceptors, to an extent comparable to that of the paralog protein GCAP1. To date, the molecular mechanisms underlying GCAP3 function remain largely unexplored. In this work, we report a thorough characterization of the biochemical and biophysical properties of human GCAP3, moreover, we identified an isolated case of retinitis pigmentosa, in which a patient carried the c.301G>C mutation in GUCA1C, resulting in the substitution of a highly conserved aspartate residue by a histidine (p.(D101H)). We found that myristoylated GCAP3 can activate GC1 with a similar Ca2+-dependent profile, but significantly less efficiently than GCAP1. The non-myristoylated form did not induce appreciable regulation of GC1, nor did the p.D101H variant. GCAP3 forms dimers under physiological conditions, but at odds with its paralogs, it tends to form temperature-dependent aggregates driven by hydrophobic interactions. The peculiar properties of GCAP3 were confirmed by 2 ms molecular dynamics simulations, which for the p.D101H variant highlighted a very high structural flexibility and a clear tendency to lose the binding of a Ca2+ ion to EF3. Overall, our data show that GCAP3 has unusual biochemical properties, which make the protein significantly different from GCAP1 and GCAP2. Moreover, the newly identified point mutation resulting in a substantially unfunctional protein could trigger retinitis pigmentosa through a currently unknown mechanism.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinose Pigmentar / Proteínas Ativadoras de Guanilato Ciclase Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinose Pigmentar / Proteínas Ativadoras de Guanilato Ciclase Idioma: En Ano de publicação: 2022 Tipo de documento: Article